18.05.2011,
in
Communications of the companies
Cerbios founder and former president, received an honorary doctorate from St. Petersburg’s Society of Oncologists
To his surprise, last March 5,Dr. Attilio Melera, Honorary Chairman of the Board of Cerbios-Pharma S.A.(henceforth "Cerbios") received the Doctorate Honoris Causa from the Scientific Society of Oncologists of St. Petersburg
12.05.2011,
in
Communications of the companies
HELSINN GROUP INVESTS IN THORNE
Helsinn Group makes an equity investment for a minority interest in Thorne Research, Inc. and plans to jointly commercialize nutritional supplement products with initial focus on meeting the needs of people living with cancer
14.03.2011,
in
Communications of the companies
mondoBIOTECH holding AG (SIX:RARE): Presenting at BIO-Europe Spring 2011 on March 16, 2011
mondoBIOTECH holding AG (SIX: RARE) newly appointed Head of Business Development & Licensing Dr. David Cox will present at the upcoming Bio-Europe Spring conference being held in Milan Italy. The presentation will take place on Wednesday March 16 at 9.15am
24.01.2011,
in
Communications of the companies
Sintetica S.A. di Mendrisio comunica l’ottenimento della approvazione da parte della Food and Drug Administration (FDA)
Questo importante risultato costituisce il raggiungimento del massimo livello di qualità richiesto dalle severissime normative americane sui farmaci iniettabili e premia la competenza e la professionalità di una azienda ticinese
26.11.2010,
in
Communications of the companies
Helsinn's grant to support Eurordis Activitie
Helsinn
15.11.2010,
in
Communications of the companies
Cerbios obtains Air Cargo Security Known Consignor Certification/2009
Cerbios-Pharma SA (from now on “Cerbios”) is proud to confirm that the UFAC (Swiss Authority of Aviation) has granted the Air Cargo Security Known Consignor Certification (from now on “Certification”) to Cerbios.
08.11.2010,
in
Communications of the companies
Helsinn continua il suo impegno a contribuire al progresso della ricerca medico-scientifico sul territorio ticinese
Contributo per l'Istituto Oncologico della Svizzera Italiana (IOSI)
01.10.2010,
in
Communications of the companies
